• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤稿声明:吡咯并[1,2 - b][1,2,5]苯并噻二氮杂卓类化合物(PBTDs)通过干扰慢性髓性白血病患者细胞中的Akt - mTOR信号传导以及bax:bcl - 2比值调节发挥其抗增殖活性。

RETRACTION: Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) Exert Their Anti-proliferative Activity by Interfering With Akt-mTOR Signaling and bax:bcl-2 Ratio Modulation in Cells From Chronic Myeloid Leukemic Patients.

出版信息

Cancer Sci. 2025 Jan;116(1):277. doi: 10.1111/cas.16390. Epub 2024 Oct 30.

DOI:10.1111/cas.16390
PMID:39478307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11711035/
Abstract

C. Di Stefano, G. Marfe, M. M. Trawinska, P. Sinibaldi-Salimei, R. Silvestri, S. Amadori and E. Abruzzese, "Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) Exert Their Anti-proliferative Activity by Interfering With Akt-mTOR Signaling and bax:bcl-2 Ratio Modulation in Cells From Chronic Myeloid Leukemic Patients," Cancer Science 101, no. 4 (2010): 991-1000, https://doi.org/10.1111/j.1349-7006.2010.01490.x. The above article, published online on 07 January 2010 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed due to several instances of duplications of western blot bands observed in Figures 3, 4, 5 and 8. Furthermore, splicing and deletion of bands was uncovered in Figures 4 and 7 respectively. Finally, western blot bands presented in Figure 4 was also found published earlier in another article. The authors provided partial raw data but the inconsistencies found could not be resolved on this basis. Due to the extent and nature of the duplications, the editors consider the results and conclusions of this study invalid.

摘要

C. 迪·斯特凡诺、G. 马尔费、M. M. 特拉温斯卡、P. 西尼巴尔迪 - 萨利梅伊、R. 西尔维斯特里、S. 阿马多里和E. 阿布鲁泽塞,“吡咯并[1,2 - b][1,2,5]苯并噻二氮杂卓(PBTDs)通过干扰慢性髓性白血病患者细胞中的Akt - mTOR信号传导和bax:bcl - 2比值调节发挥其抗增殖活性”,《癌症科学》101卷,第4期(2010年):991 - 1000页,https://doi.org/10.1111/j.1349 - 7006.2010.01490.x。上述文章于2010年1月7日在线发表于威利在线图书馆(wileyonlinelibrary.com),已根据期刊主编武山正典、日本癌症协会和约翰威利父子澳大利亚有限公司之间的协议撤回。撤回是由于在图3、4、5和8中观察到多次蛋白质免疫印迹条带重复的情况。此外,分别在图4和7中发现了条带的拼接和缺失。最后,图4中呈现的蛋白质免疫印迹条带也被发现在另一篇文章中更早发表。作者提供了部分原始数据,但在此基础上发现的不一致之处无法得到解决。由于重复的程度和性质,编辑们认为这项研究的结果和结论无效。

相似文献

1
RETRACTION: Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) Exert Their Anti-proliferative Activity by Interfering With Akt-mTOR Signaling and bax:bcl-2 Ratio Modulation in Cells From Chronic Myeloid Leukemic Patients.撤稿声明:吡咯并[1,2 - b][1,2,5]苯并噻二氮杂卓类化合物(PBTDs)通过干扰慢性髓性白血病患者细胞中的Akt - mTOR信号传导以及bax:bcl - 2比值调节发挥其抗增殖活性。
Cancer Sci. 2025 Jan;116(1):277. doi: 10.1111/cas.16390. Epub 2024 Oct 30.
2
RETRACTION: Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI.撤稿声明:泽布替尼通过抑制ARHI甲基化增强人骨肉瘤细胞凋亡。
Cancer Sci. 2024 Dec;115(12):4080. doi: 10.1111/cas.16346. Epub 2024 Sep 16.
3
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) exert their anti-proliferative activity by interfering with Akt-mTOR signaling and bax:bcl-2 ratio modulation in cells from chronic myeloid leukemic patients.吡咯并[1,2-b][1,2,5]苯并噻二嗪(PBTDs)通过干扰慢性髓系白血病患者细胞中的 Akt-mTOR 信号和 bax:bcl-2 比值调节来发挥其抗增殖活性。
Cancer Sci. 2010 Apr;101(4):991-1000. doi: 10.1111/j.1349-7006.2010.01490.x.
4
RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation.撤稿声明:外泌体miR-106a-5p通过FBXW7介导的TRIM24降解加速鼻咽癌进展。
Cancer Sci. 2024 Nov;115(11):3829. doi: 10.1111/cas.16312. Epub 2024 Aug 21.
5
Retraction.撤回。
Cancer Sci. 2023 Jul;114(7):3057. doi: 10.1111/cas.15809. Epub 2023 May 22.
6
RETRACTION: Role of the MUC1-C Oncoprotein in the Acquisition of Cisplatin Resistance by Urothelial Carcinoma.撤稿声明:MUC1-C癌蛋白在尿路上皮癌获得顺铂耐药性中的作用。
Cancer Sci. 2025 Apr;116(4):1154. doi: 10.1111/cas.70016. Epub 2025 Feb 11.
7
Retraction.撤回。
Int J Cancer. 2019 Aug 15;145(4):1165. doi: 10.1002/ijc.32281. Epub 2019 Mar 29.
8
RETRACTION: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.撤回声明:微小RNA-16通过抑制BCL2以及核因子-κB1/基质金属蛋白酶-9信号通路来抑制胶质瘤细胞的生长和侵袭。
Cancer Sci. 2024 Sep;115(9):3200. doi: 10.1111/cas.16269. Epub 2024 Jul 22.
9
Retraction: Tongyi Lu, Binhua Wu, Yunfei Yu, Wenhui Zhu, Simin Zhang, Yinmei Zhang, Jiaying Guo, Ning Deng. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018; 109: 2221-2234. https://doi.org/10.1111/cas.13633.撤稿声明:陆通一、吴炳华、余云飞、朱文慧、张思敏、张银梅、郭嘉莹、邓宁。卵巢癌中ONECUT2表达的阻断抑制肿瘤细胞增殖、迁移、侵袭和血管生成。《癌症科学》。2018年;109: 2221 - 2234。https://doi.org/10.1111/cas.13633 。
Cancer Sci. 2024 Apr;115(4):1360. doi: 10.1111/cas.16108. Epub 2024 Feb 11.
10
RETRACTION: miR-25-3p Reverses Epithelial-Mesenchymal Transition via Targeting Sema4C in Cisplatin-Resistance Cervical Cancer Cells.撤回声明:miR-25-3p通过靶向顺铂耐药宫颈癌细胞中的Sema4C逆转上皮-间质转化。
Cancer Sci. 2025 Jul;116(7):2047. doi: 10.1111/cas.70083. Epub 2025 Apr 30.